Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Tuesday broker round-up

Tue, 02nd Mar 2021 14:00

(Sharecast News) - Sumo Group: Canaccord upgrades to buy with a target price of 340p.



BAE Systems: Berenberg reiterates buy with a target price of 600p.

Anglo Pacific Group: Berenberg reiterates buy with a target price of 150p.

Spectris: Berenberg reiterates buy with a target price of 3,505p.

Provident Financial Group: Canaccord reiterates sell with a target price of 264p.

Astrazeneca: Citigroup reiterates buy.

Bunzl: Barclays reiterates equal weight with a target price of 2,350p.

IMI: Barclays reiterates overweight with a target price of 1,465p.

Restaurant Group: Liberum reiterates buy with a target price of 135p.

Energean: Peel Hunt reiterates buy with a target price of 1,100p.

Related Shares

More News
Today 13:00

German vaccine panel endorses Astra-Sanofi's RSV shot for infants

FRANKFURT, June 27 (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca a...

26 Jun 2024 08:40

TOP NEWS: AstraZeneca's Tagrisso plus chemo gets approval in China

(Alliance News) - AstraZeneca PLC on Wednesday celebrated the approval of Tagrisso plus chemotherapy for a cancer form in China, a day after a similar...

25 Jun 2024 09:05

TOP NEWS: AstraZeneca details mixed findings from cancer drug trials

(Alliance News) - AstraZeneca PLC on Tuesday announced a mixed bag of results for two of its leading cancer drugs Imfinzi and Tagrisso.

25 Jun 2024 07:48

LONDON BRIEFING: Mixed bag for Astra drug; Landsec ups Bluewater stake

(Alliance News) - London's FTSE 100 is set to tread water on Tuesday, with a slump for US tech shares overnight keeping a lid on enthusiasm.

25 Jun 2024 07:17

AstraZeneca posts mixed results from recent Imfinzi trials

(Sharecast News) - AstraZeneca announced contrasting results from two phase three trials involving its immunotherapy drug 'Imfinzi', or durvalumab, on...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.